Companies / new-land

New Land

ChinaTechnology & Electronics

Overview

Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China. The company offers pharmaceutical intermediates, including L-4-hydroxyphenylglycine methyl ester, L-hydroxyphenylglycine potassium salt, L-4-hydroxyphenylglycine, and p-Toluenesulfonic acid. It also provides APIs, such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, tadalafil,

Employees981
Market Cap$3.7B
Revenue$659.5M
Listed OnShenzhen Stock Exchange
Ticker301277
CEOMr. Luwei Zhang
HeadquartersChangge

Website

https://www.newlandpharma.com